FI954944A - Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon - Google Patents
Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon Download PDFInfo
- Publication number
- FI954944A FI954944A FI954944A FI954944A FI954944A FI 954944 A FI954944 A FI 954944A FI 954944 A FI954944 A FI 954944A FI 954944 A FI954944 A FI 954944A FI 954944 A FI954944 A FI 954944A
- Authority
- FI
- Finland
- Prior art keywords
- migraine
- treatment
- pct
- indole derivatives
- agonists used
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939308360A GB9308360D0 (en) | 1993-04-22 | 1993-04-22 | Indoles |
| GB939324433A GB9324433D0 (en) | 1993-11-27 | 1993-11-27 | Indoles |
| PCT/EP1994/001121 WO1994024127A1 (en) | 1993-04-22 | 1994-04-11 | Indole derivatives as 5-h1-like agonists for use in migraine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI954944A true FI954944A (fi) | 1995-10-17 |
| FI954944A0 FI954944A0 (fi) | 1995-10-17 |
Family
ID=26302791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI954944A FI954944A0 (fi) | 1993-04-22 | 1995-10-17 | Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5607960A (es) |
| EP (1) | EP0695301B1 (es) |
| JP (1) | JP2802169B2 (es) |
| KR (1) | KR960701865A (es) |
| CN (1) | CN1121348A (es) |
| AT (1) | ATE144773T1 (es) |
| AU (1) | AU6567094A (es) |
| BR (1) | BR9406481A (es) |
| CA (1) | CA2157397C (es) |
| CZ (1) | CZ274595A3 (es) |
| DE (1) | DE69400824T2 (es) |
| DK (1) | DK0695301T3 (es) |
| ES (1) | ES2094653T3 (es) |
| FI (1) | FI954944A0 (es) |
| GR (1) | GR3021804T3 (es) |
| HU (1) | HUT73807A (es) |
| IL (1) | IL109337A0 (es) |
| NO (1) | NO954168D0 (es) |
| NZ (1) | NZ265269A (es) |
| PL (1) | PL311204A1 (es) |
| WO (1) | WO1994024127A1 (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| AU686654B2 (en) * | 1993-08-31 | 1998-02-12 | Pfizer Inc. | 5-arylindole derivatives |
| GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| GB9420503D0 (en) * | 1994-10-11 | 1994-11-23 | Pfizer Ltd | Therapeutic agents |
| GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
| TR199700993T1 (xx) * | 1995-03-20 | 1998-03-21 | Eli Lilly And Company | 5-ikameli-3-(1,2,3,6-tetrahidropridin-4-il)- ve 3-(piperidin-4-il)-1H-indoller: yeni 5-HT1F agonistler. |
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
| US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| AU4074897A (en) * | 1996-09-18 | 1998-04-14 | Eli Lilly And Company | A method for the prevention of migraine |
| ATE251136T1 (de) * | 1996-11-26 | 2003-10-15 | Nps Allelix Corp | 5-cyclo-indolverbindungen als 5-ht1d rezeptor liganden |
| US5998462A (en) * | 1996-12-16 | 1999-12-07 | Allelix Biopharmaceuticals Inc. | 5-alkyl indole compounds |
| US5856510A (en) * | 1996-12-16 | 1999-01-05 | Allelix Biopharmaceuticals Inc. | 5-alkenyl and 5-alkynyl indole compounds |
| GB9705035D0 (en) * | 1997-03-11 | 1997-04-30 | Pharmacia & Upjohn Spa | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| EP0875513A1 (en) * | 1997-04-14 | 1998-11-04 | Eli Lilly And Company | Substituted heteroaromatic 5-HT 1F agonists |
| EP1003738B1 (en) * | 1997-08-09 | 2003-11-19 | SmithKline Beecham plc | Bicyclic compounds as ligands for 5-ht1 receptors |
| US6310066B1 (en) | 1998-04-29 | 2001-10-30 | American Home Products Corp. | Antipsychotic indolyl derivatives |
| US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| US6066637A (en) * | 1998-06-19 | 2000-05-23 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| WO2000000490A2 (en) * | 1998-06-26 | 2000-01-06 | Eli Lilly And Company | 5-ht1f agonists |
| US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
| CN1264838C (zh) * | 2000-07-21 | 2006-07-19 | H·隆德贝克有限公司 | 用于治疗中枢神经系统疾病的吲哚衍生物 |
| US6489512B1 (en) * | 2002-06-21 | 2002-12-03 | Rhodia Chirex Inc. | Method for making aryl hydrazines and substituted indoles |
| EP1569930B1 (en) * | 2002-12-10 | 2007-01-03 | MERCK PATENT GmbH | Indol derivatives and their use as 5-ht ligands |
| EP1572647B1 (en) * | 2002-12-20 | 2016-09-21 | Basf Se | Synthesis of amines and intermediates for the synthesis thereof |
| EP1575566B1 (en) * | 2002-12-26 | 2012-02-22 | Pozen, Inc. | Multilayer dosage forms containing naproxen and triptans |
| BRPI0410807A (pt) * | 2003-06-06 | 2006-06-27 | Glaxo Group Ltd | composição farmacêutica, e, método pata tratar um mamìfero sofrendo de ou susceptìvel a condições associadas com dor cefálica |
| US20050245540A1 (en) * | 2003-12-09 | 2005-11-03 | Fujisawa Pharmaceutical Co., Ltd. | New methods |
| WO2005066157A1 (en) * | 2004-01-02 | 2005-07-21 | Suven Life Sciences | 3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators |
| GB0807772D0 (en) * | 2008-04-29 | 2008-06-04 | Lectus Therapeutics Ltd | Calcium ion modulators and uses thereof |
| FR2953720B1 (fr) * | 2009-12-11 | 2012-05-11 | Oreal | Utilisation de derives de benzyloxy-ethylamines comme conservateur, |
| CN104557957B (zh) * | 2013-10-09 | 2017-04-19 | 华东师范大学 | 螺‑氧化吲哚环氧乙烷衍生物的合成方法 |
| KR20220137085A (ko) * | 2020-02-04 | 2022-10-11 | 마인드셋 파마 인크. | Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 3-피롤리딘-인돌 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8530507D0 (en) * | 1985-12-11 | 1986-01-22 | Glaxo Group Plc | Chemical compounds |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| HUT64326A (en) * | 1990-10-15 | 1993-12-28 | Pfizer | Process for production indole derivatives and pharmaceutical preparations containing these compounds |
-
1994
- 1994-04-11 PL PL94311204A patent/PL311204A1/xx unknown
- 1994-04-11 CA CA002157397A patent/CA2157397C/en not_active Expired - Fee Related
- 1994-04-11 KR KR1019950704623A patent/KR960701865A/ko not_active Application Discontinuation
- 1994-04-11 WO PCT/EP1994/001121 patent/WO1994024127A1/en not_active Application Discontinuation
- 1994-04-11 AU AU65670/94A patent/AU6567094A/en not_active Abandoned
- 1994-04-11 BR BR9406481A patent/BR9406481A/pt not_active Application Discontinuation
- 1994-04-11 ES ES94913573T patent/ES2094653T3/es not_active Expired - Lifetime
- 1994-04-11 DE DE69400824T patent/DE69400824T2/de not_active Expired - Fee Related
- 1994-04-11 EP EP94913573A patent/EP0695301B1/en not_active Expired - Lifetime
- 1994-04-11 NZ NZ265269A patent/NZ265269A/en unknown
- 1994-04-11 CN CN94191850A patent/CN1121348A/zh active Pending
- 1994-04-11 JP JP6522726A patent/JP2802169B2/ja not_active Expired - Fee Related
- 1994-04-11 DK DK94913573.5T patent/DK0695301T3/da active
- 1994-04-11 AT AT94913573T patent/ATE144773T1/de not_active IP Right Cessation
- 1994-04-11 HU HU9501920A patent/HUT73807A/hu unknown
- 1994-04-11 CZ CZ952745A patent/CZ274595A3/cs unknown
- 1994-04-11 US US08/532,573 patent/US5607960A/en not_active Expired - Fee Related
- 1994-04-18 IL IL10933794A patent/IL109337A0/xx unknown
-
1995
- 1995-10-17 FI FI954944A patent/FI954944A0/fi not_active Application Discontinuation
- 1995-10-19 NO NO954168A patent/NO954168D0/no unknown
-
1996
- 1996-11-28 GR GR960403195T patent/GR3021804T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2157397C (en) | 1999-07-06 |
| PL311204A1 (en) | 1996-02-05 |
| NO954168L (no) | 1995-10-19 |
| DE69400824D1 (de) | 1996-12-05 |
| AU6567094A (en) | 1994-11-08 |
| JPH08507083A (ja) | 1996-07-30 |
| NZ265269A (en) | 1996-09-25 |
| CZ274595A3 (en) | 1996-03-13 |
| NO954168D0 (no) | 1995-10-19 |
| FI954944A0 (fi) | 1995-10-17 |
| CA2157397A1 (en) | 1994-10-27 |
| ATE144773T1 (de) | 1996-11-15 |
| EP0695301A1 (en) | 1996-02-07 |
| EP0695301B1 (en) | 1996-10-30 |
| WO1994024127A1 (en) | 1994-10-27 |
| DE69400824T2 (de) | 1997-03-13 |
| BR9406481A (pt) | 1996-01-09 |
| HU9501920D0 (en) | 1995-09-28 |
| CN1121348A (zh) | 1996-04-24 |
| GR3021804T3 (en) | 1997-02-28 |
| US5607960A (en) | 1997-03-04 |
| KR960701865A (ko) | 1996-03-28 |
| JP2802169B2 (ja) | 1998-09-24 |
| IL109337A0 (en) | 1994-07-31 |
| HUT73807A (en) | 1996-09-30 |
| ES2094653T3 (es) | 1997-01-16 |
| DK0695301T3 (da) | 1996-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI954944A (fi) | Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon | |
| DK0544819T3 (da) | Indolderivater, som inhiberer leukotrienbiosyntese | |
| FI960399A0 (fi) | Perhydroisoindolijohdannaisia P-aineen antagonisteina | |
| DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
| DK0771197T3 (da) | Anvendelse af heterocykliske forbindelser som dopamin-D3-ligander | |
| ES2121193T3 (es) | Derivados de bencimidazoles. | |
| DK0699104T3 (da) | Fremgangsmåde til underkritisk tørring af aerogeler | |
| NO20005237D0 (no) | Heterocyklisk substituerte amider anvendt som calpain- inhibitorer | |
| DK0641328T3 (da) | Broforbundne, azabicykliske derivater som substans P-antagonister | |
| DE69401204D1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
| DK0778771T3 (da) | Topiske ketoconazolemulsioner | |
| NO992282D0 (no) | Benzonaftyridiner som bronkialterapentika | |
| FI970147A (fi) | Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina | |
| DK0941221T3 (da) | Substituerede dihydrobenzofuraner som PDE-inhibitorer | |
| ES2124893T3 (es) | Nuevos complejos de inclusion de sales de nimesulida y de ciclodextrina. | |
| NO963331L (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| NO20002408L (no) | 5-HT1F antagonister | |
| YU29496A (sh) | So pirolidinil metil indola | |
| ES2181791T3 (es) | Derivados de indol para el tratamiento de la migraña. | |
| ATE221068T1 (de) | Anellierte beta-carboline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |